LOREA _ ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF LORLATINIB IN UNTREATED ALK-POSITIVE NSCLC PATIENTS IN A FRENCH REAL-WORLD CONTEXT

01/07/2026
01/07/2026
EU PAS number:
EUPAS1000000111
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information